• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同外周动脉疾病阶段的十年死亡率:基于人群的预后观察研究。

Ten Year Mortality in Different Peripheral Arterial Disease Stages: A Population Based Observational Study on Outcome.

机构信息

Section of Vascular Surgery, Department of Clinical Science and Education, Karolinska Institutet at Södersjukhuset, Stockholm, Sweden.

Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

出版信息

Eur J Vasc Endovasc Surg. 2018 Apr;55(4):529-536. doi: 10.1016/j.ejvs.2018.01.019. Epub 2018 Feb 23.

DOI:10.1016/j.ejvs.2018.01.019
PMID:29478910
Abstract

OBJECTIVE

The aim was to determine long-term mortality rates and the underlying cause of death for subjects with different peripheral arterial disease (PAD) stages in a population based setting.

METHODS

A randomly selected population sample of 5080 subjects was enrolled in the study in 2004-2005. Participants completed health state questionnaires and underwent ankle brachial index (ABI) measurements for classification into PAD severity stages and reference subjects. A follow-up was conducted by the end of 2015 using data from Swedish governmental national registers for cause of death, which was then compared with PAD stage determined at baseline in 2005.

RESULTS

The 10 year all cause mortality was 27% for reference cases, 56% for asymptomatic PAD (APAD), 63% for intermittent claudication (IC), and 75% for severe limb ischaemia (SLI). Among all PAD subjects, cardiovascular (CV) causes were the most common main cause of death (45%) and a CV event was present as either the main or one of the three most common contributing causes of death in 64% of the cases. The age adjusted hazard ratios for a main cause of death by a CV event were 1.9 (95% CI 1.5-2.3) for APAD, 2.6 (95% CI 2.1-3.4) for IC, and 3.5 (95% CI 2.3-5.2) for SLI.

CONCLUSION

PAD subjects, including the APAD subjects, are still at high risk of CV death. The mortality risks are more than doubled in symptomatic PAD patients compared with reference subjects and increase by severity of PAD stage. Awareness and improved risk reduction management of PAD are still warranted.

摘要

目的

本研究旨在确定在人群中不同外周动脉疾病(PAD)阶段患者的长期死亡率和死亡原因。

方法

在 2004-2005 年,本研究从一个随机选择的人群样本中招募了 5080 名受试者。参与者完成了健康状况问卷,并进行了踝肱指数(ABI)测量,以确定 PAD 严重程度分期和参考受试者。通过瑞典政府全国登记册获取截至 2015 年底的死亡原因随访数据,并与 2005 年基线时确定的 PAD 分期进行比较。

结果

参考病例的 10 年全因死亡率为 27%,无症状 PAD(APAD)为 56%,间歇性跛行(IC)为 63%,严重肢体缺血(SLI)为 75%。在所有 PAD 患者中,心血管(CV)疾病是最常见的主要死亡原因(45%),64%的病例中 CV 事件是主要或三个最常见死亡原因之一。经年龄调整后,CV 事件导致主要死亡原因的风险比(HR)为 APAD 1.9(95%CI 1.5-2.3),IC 为 2.6(95%CI 2.1-3.4),SLI 为 3.5(95%CI 2.3-5.2)。

结论

包括无症状 PAD 患者在内的 PAD 患者仍然存在较高的 CV 死亡风险。与参考受试者相比,有症状 PAD 患者的死亡率风险增加了一倍以上,且随着 PAD 严重程度分期的增加而增加。仍然需要提高对 PAD 的认识并改善风险降低管理。

相似文献

1
Ten Year Mortality in Different Peripheral Arterial Disease Stages: A Population Based Observational Study on Outcome.不同外周动脉疾病阶段的十年死亡率:基于人群的预后观察研究。
Eur J Vasc Endovasc Surg. 2018 Apr;55(4):529-536. doi: 10.1016/j.ejvs.2018.01.019. Epub 2018 Feb 23.
2
Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.接受血运重建的外周动脉疾病患者的当代心血管风险及二级预防药物治疗模式
J Vasc Surg. 2016 Oct;64(4):1009-1017.e3. doi: 10.1016/j.jvs.2016.03.429. Epub 2016 May 18.
3
Matrix metalloproteinase 10 is associated with disease severity and mortality in patients with peripheral arterial disease.基质金属蛋白酶10与外周动脉疾病患者的疾病严重程度和死亡率相关。
J Vasc Surg. 2015 Feb;61(2):428-35. doi: 10.1016/j.jvs.2014.09.002. Epub 2014 Oct 23.
4
Cardiovascular long-term outcome and prophylactic treatment patterns in peripheral arterial disease in a population-based cohort.基于人群的外周动脉疾病心血管长期结局和预防治疗模式。
Eur Heart J Qual Care Clin Outcomes. 2019 Oct 1;5(4):310-320. doi: 10.1093/ehjqcco/qcz037.
5
Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study.外周动脉疾病作为动脉粥样硬化疾病初始或后续表现患者的心血管结局:一项瑞典全国性研究的结果
J Vasc Surg. 2017 Aug;66(2):507-514.e1. doi: 10.1016/j.jvs.2017.01.067. Epub 2017 Apr 19.
6
Ankle-brachial index in patients with intermittent claudication is a poor indicator of patient-centered and clinician-based evaluations of functional status.间歇性跛行患者的踝臂指数是患者为中心和基于临床医生的功能状态评估的不良指标。
J Vasc Surg. 2019 Mar;69(3):906-912. doi: 10.1016/j.jvs.2018.07.039. Epub 2019 Jan 6.
7
Alcohol consumption and outcome in stable outpatients with peripheral artery disease.酒精摄入与外周动脉疾病稳定门诊患者的预后。
J Vasc Surg. 2011 Oct;54(4):1081-7. doi: 10.1016/j.jvs.2011.03.285.
8
A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences.一项基于人群的外周动脉疾病患病率研究,特别关注严重肢体缺血和性别差异。
J Vasc Surg. 2007 Jun;45(6):1185-91. doi: 10.1016/j.jvs.2007.02.004.
9
Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes.根据年龄和糖尿病对有症状外周动脉疾病患者的死亡率和死亡率预测因素进行分层。
J Vasc Surg. 2014 May;59(5):1291-9. doi: 10.1016/j.jvs.2013.11.063. Epub 2014 Jan 3.
10
The Risk of Disease Progression in Peripheral Arterial Disease is Higher than Expected: A Meta-Analysis of Mortality and Disease Progression in Peripheral Arterial Disease.外周动脉疾病的疾病进展风险高于预期:一项外周动脉疾病死亡率和疾病进展的荟萃分析。
Eur J Vasc Endovasc Surg. 2016 Mar;51(3):395-403. doi: 10.1016/j.ejvs.2015.10.022. Epub 2016 Jan 6.

引用本文的文献

1
Surfactant protein-D is an independent predictor of all-cause mortality in men with peripheral artery disease diagnosed by population-based screening.表面活性蛋白-D是通过基于人群的筛查诊断出的外周动脉疾病男性患者全因死亡率的独立预测指标。
Front Cardiovasc Med. 2025 May 20;12:1534779. doi: 10.3389/fcvm.2025.1534779. eCollection 2025.
2
Current diagnostic and therapeutic approaches for peripheral arterial disease in Italy: a survey among vascular specialists of the Italian society of angiology and vascular medicine (SIAPAV) and general practitioners of the Italian federation of general practitioners (FIMMG).意大利外周动脉疾病的当前诊断和治疗方法:对意大利血管病学和血管医学学会(SIAPAV)的血管专家以及意大利全科医生联合会(FIMMG)的全科医生进行的一项调查。
Intern Emerg Med. 2025 May 30. doi: 10.1007/s11739-025-03974-8.
3
Deciphering the Role of Ferroptosis in the Pathogenesis of Peripheral Artery Disease Myopathy.解读铁死亡在周围动脉疾病性肌病发病机制中的作用。
Biology (Basel). 2025 May 12;14(5):537. doi: 10.3390/biology14050537.
4
Incidence and predictors of cardiovascular disease mortality and all-cause mortality in patients with type II diabetes with peripheral arterial disease.2型糖尿病合并外周动脉疾病患者心血管疾病死亡率和全因死亡率的发生率及预测因素
PLoS One. 2025 May 16;20(5):e0322502. doi: 10.1371/journal.pone.0322502. eCollection 2025.
5
Distribution of lipoprotein (a) levels in patients with lower extremity artery disease and their impact on amputation and survival: a retrospective study.下肢动脉疾病患者脂蛋白(a)水平分布及其对截肢和生存的影响:一项回顾性研究
Lipids Health Dis. 2025 Apr 2;24(1):128. doi: 10.1186/s12944-025-02542-5.
6
Application of the chocolate balloon (restrictive dilatation technique) in vascular preparation for arterial angioplasty of the lower limbs.巧克力球囊(限制性扩张技术)在下肢动脉血管成形术血管准备中的应用。
Front Surg. 2025 Mar 7;12:1528231. doi: 10.3389/fsurg.2025.1528231. eCollection 2025.
7
Wound formation in patients with Rutherford category IV disease after endovascular therapy: rates and risk factors.血管内治疗后卢瑟福IV级疾病患者的伤口形成:发生率及危险因素
CVIR Endovasc. 2024 Dec 7;7(1):86. doi: 10.1186/s42155-024-00500-3.
8
The functions of apolipoproteins and lipoproteins in health and disease.载脂蛋白和脂蛋白在健康和疾病中的功能。
Mol Biomed. 2024 Oct 28;5(1):53. doi: 10.1186/s43556-024-00218-7.
9
Temporal Trends and Mortality Patterns in Peripheral Arterial Disease: A Comprehensive Analysis of Hospitalized Patients in Kazakhstan between 2014 and 2021.外周动脉疾病的时间趋势和死亡率模式:对2014年至2021年哈萨克斯坦住院患者的综合分析
J Epidemiol Glob Health. 2024 Dec;14(4):1609-1618. doi: 10.1007/s44197-024-00313-6. Epub 2024 Oct 14.
10
Drug-eluting devices for lower limb peripheral arterial disease.药物洗脱装置治疗下肢外周动脉疾病。
EuroIntervention. 2024 Sep 16;20(18):e1136-e1153. doi: 10.4244/EIJ-D-23-01080.